This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

LipiGesic M Is The Only Recommended First-line Therapy For Acute Migraine That Has No Evidence Of Rebound Headache

When comparing LipiGesic M to a comprehensive list published by the Cleveland Clinic of both over-the-counter and prescription formulations for the treatment of acute migraine headaches, it stands alone as a viable migraine treatment without risk of rebound headache. The extensive list that was published on the Cleveland Clinic website includes: "aspirin, sinus relief medications, acetaminophen, nonsteroidal anti-inflammatory medications (NSAIDs), sedatives for sleep, codeine and prescription narcotics, and over-the-counter combination headache remedies containing caffeine (such as Anacin ®, Excedrin ®, Bayer Select ®, and others).

"Other medications commonly associated with rebound headaches are ergotamine preparations (Cafergot ®, Migergot ®, Ergomar ®, Bellergal-S ®, Bel-Phen-Ergot S ®, Phenerbel-S ®, Ercaf ®, Wigraine ® and Cafatine PB ®), butalbital combination analgesics (Goody's Headache Powder ®, Supac ®, Excedrin ®, Fiorinal ®) and opiates (codeine). The triptans – which are migraine-specific medications and include Imitrex ®, Zomig ®, Maxalt ®, Relpax ®, Axert ®, Frova ®, Amerge ®, and Treximet ® – taken more than 2 times per week can also cause rebound headaches."

Medication-overuse headache is related to common OTC medications.

In the article, "Doctor Says Painkillers Cause Epidemic of Child Headaches," which was published on August 2, 2013 in the Herald Scotland, Dr. Ishaq Abu-Arafeh, who runs a headache clinic at the Royal Hospital for Sick Children in Yokhill, Glasgow, Scotland, states there has been an increase in children who are suffering from headaches because they are either consuming too much caffeine or too much paracetamol, which is known as acetaminophen in the U.S.

Dr. Abu-Arafeh explained, "prolonged use of paracetamol and ibuprofen can dull pain for a short time but makes the head more sensitive and more likely to feel sore."

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.75 -0.53%
FB $118.16 0.30%
GOOG $704.02 0.37%
TSLA $211.03 -0.24%
YHOO $36.75 -0.51%


Chart of I:DJI
DOW 17,604.69 -56.02 -0.32%
S&P 500 2,040.89 -9.74 -0.47%
NASDAQ 4,686.5440 -30.55 -0.65%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs